People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotech / Pharma, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Colossal Biosciences Inc. | — | Biotech / Pharma | Series D+ | $162.6M | $2.8B | 2023 |
| LOKL Energy, Inc. | — | Other Energy | Series A | $6.9M | $5.1M | 2021 |
Tom Chi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tom Chi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Benjamin Lamm | 1 | 4 |
| Wade Webster | 1 | 3 |
| Brian Beard | 1 | 2 |
| Louis Lalonde | 1 | 1 |
| Federico Jack | 1 | 1 |
| Ignacio Juarez | 1 | 1 |
| Charles Orbell | 1 | 1 |
| James Rebello | 1 | 1 |
| Michael Dilick | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.